Stay updated on HER2+ Breast Cancer Adjuvant Trial

Sign up to get notified when there's something new on the HER2+ Breast Cancer Adjuvant Trial page.
Latest website image capture
Clouds background image

Latest updates to the HER2+ Breast Cancer Adjuvant Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page has been updated to version 2.16.5, and the previous version 2.16.4 has been removed. Additionally, a significant piece of information regarding the modernization of ClinicalTrials.gov data ingest in July 2025 has been deleted.
    Difference
    1%
    Check dated 2025-07-04T04:18:53.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been pushed back from June 2025 to July 2025.
    Difference
    1%
    Check dated 2025-06-19T20:11:32.000Z thumbnail image
  4. Check
    29 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-05T11:25:39.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    2%
    Check dated 2025-05-29T06:13:06.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-04-30T19:20:41.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    The page has undergone significant changes, including the removal of detailed descriptions of a clinical trial comparing treatments for HER2-positive breast cancer, while retaining some key identifiers such as the EudraCT number and the study's location.
    Difference
    41%
    Check dated 2025-04-16T13:24:31.000Z thumbnail image

Stay in the know with updates to HER2+ Breast Cancer Adjuvant Trial

Enter your email address, and we'll notify you when there's something new on the HER2+ Breast Cancer Adjuvant Trial page.